Cable Viewer

Currently released so far... 12477 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/06
1986/05
1987/06
1988/01
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/06 1992/12
1993/10
1996/11
1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ASEC AF AFIN AM AJ AG AS AEMR AMGT AORC APER AU ACBAQ AFGHANISTAN AR AE ADANA ADPM APECO AMED AX AL ADCO AA AECL AADP AMEX ACAO ANET AODE ASCH AY APEC AID AORG ASEAN ABUD AGAO AFSI AFSN AINF AGR AROC AO AFFAIRS ASIG ABLD ASUP AND ARM AQ ATFN AC ATRN ACOA AMBASSADOR AUC ASEX ARF AER AVERY AGRICULTURE AMG AFU AN AORL ALOW APCS AZ AMCHAMS ADM ACABQ AGMT ASECKFRDCVISKIRFPHUMSMIGEG AIT ACS
BR BK BA BRUSSELS BEXP BM BD BL BO BILAT BU BN BT BX BTIO BIDEN BG BE BP BY BBSR BC BTIU BWC BB BF BH BMGT
CO CASC CS CA CONDOLEEZZA CE CVIS CU CPAS CMGT COUNTER CH COUNTRY CJAN CG CIDA CJUS CI CY CD CDG CBSA CEUDA CR CM CLMT CAC CBW CODEL COPUOS CIC CW CBE CHR CFED CT CONS CWC CTM CDC CVR CF CIA CLINTON COUNTERTERRORISM CITEL CLEARANCE COE CN CACS CAN CB CSW CITT CARSON CACM CDB COM CV CAPC CKGR CBC CTR CNARC CROS CARICOM CL CICTE CIS
DR DHS DA DJ DEA DPRK DEPT DOMESTIC DOE DS DE DEFENSE DO DAO DCM DEAX DK DTRA DISENGAGEMENT DOD
EINV ETRD ECON EPET ENRG EAGR EC EFIN EAID ELTN EIND ELAB EAIR ECIN EUN EG EU ETTC ET EI EWWT EFIS EMIN ER EPA ENVI ENGR ETRC EXTERNAL ECPS EN ELN EINT ETRDEINVTINTCS ES EZ ETRO ETRDEINVECINPGOVCS EDU ETRN EFTA EAIG EK EUREM ECONCS ECONOMICS ENVR ELECTIONS EAP ENIV ECONOMY ESA EINN ECONOMIC EIAR EXBS ECA ECUN EINDETRD EUR EREL EUC ESENV ECONEFIN ECIP ENERG EFIM EAIDS ETRDECONWTOCS EUNCH EINVETC ENGY EINVECONSENVCSJA EUMEM ETRA EINVEFIN ETC ERD ENNP EFINECONCS ECINECONCS ERNG EXIM EURN EEPET
FR FREEDOM FTA FJ FARC FI FTAA FAC FBI FOREIGN FOI FM FAO FAS FINR FDA FOR FINANCE FMLN FO FISO
GTMO GG GM GV GOV GOI GL GH GA GY GT GAERC GR GF GCC GE GZ GTIP GLOBAL GANGS GERARD GAZA
HO HA HR HUMAN HK HU HILLARY HI HSTC HURI HYMPSK HUMOR HEBRON
IR IAEA IS IZ IN IT IO IAHRC ID IC IRAQI IWC ISLAMISTS IV ICAO INDO ITPHUM ITPGOV ITALIAN IPR ICRC INTERPOL IQ IBET IMO INR INTERNAL ICJ ICTY IRS ILO ISRAELI IEA INRB ITALY IL ITU ITRA IBRD IIP ILC IZPREL IMF IRAJ IA ITF IF INMARSAT ISRAEL ICTR IDP IGAD IEFIN IACI INRA INRO INTELSAT IRC IDA
JA JO JUS JP JOSEPH JM JAMES JOHNNIE JOHN
KS KN KTFN KTDB KTIP KIRF KPAO KDEM KCOR KE KMPI KSCA KZ KG KNUP KNNP KPAL KCRM KIPR KPKO KFLO KSEP KOMC KISL KNNPMNUC KWBG KFRD KUNR KWMN KSTC KFLU KOLY KMDR KJUS KSTH KAWC KU KWAC KNPP KERG KSEO KACT KHLS KGHG KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KDRG KTIA KVPR KV KIDE KICC KPRP KBIO KSUM KGIT KCFE KBTS KCIP KGIC KPAI KTLA KTEX KFSC KPLS KHIV KCSY KSAC KTRD KID KMRS KOM KSAF KRVC KR KMOC KNAR KHDP KSPR KBTR KOCI KJUST KNEI KAWK KGCC KMCA KBCT KREL KMFO KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KFTFN KVRP KIRC KCOM KO KLIG KAID KNSD KHUM KSEC KRAD KCMR KPWR KCHG KICA KPIN KESS KDEV KCGC KWWMN KPRV KPAK KWNM KWMNCS KRFD KVIR KSCI KDDG KIFR KHSA KCRS KRGY KCRCM KFIN KPOA KCFC KTER KREC KMIG KTBT KRCM KRIM KWMM KOMS KX KPAONZ KNUC KDEMAF
LE LY LG LH LI LTTE LAB LOG LA LT LO LU LABOR
MP MY MOPS MCAP MARR MNUC MUCN MTCRE MASS MAPP MIL MX MEDIA MO MPOS MU ML MA MERCOSUR MG MD MW MK MAS MT MI MOPPS MASC MR MTS MLS MILI MAR MTRE MEPN MTCR MEPI MQADHAFI MAPS MARAD MEETINGS MEPP MILITARY MZ MDC MC MCC MASSMNUC MRCRE MV MIK
NU NZ NATO NPT NL NI NAFTA NDP NIPP NP NG NRR NO NEW NE NH NR NA NS NSF NZUS NATIONAL NSG NC NT NAR NK NV NORAD NSSP NASA NATOPREL NPA NW NPG NSFO NGO NSC
OVIP OPIC OEXC OTRA OPDC OREP OAS OPRC OIIP OSCE OFFICIALS OMIG ODIP OFDP OECD OBSP OPCW OTR OSAC OSCI ON OCII OES OPAD OIC OFDA OHUM OVP OIE OCS
PGOV PINR PREL PHSA PTER PE PREF PHUM PK PARM PINS PM PL PO PA PBTS PBIO POL PARMS PROG PAK POLITICS PORG PTBS PNAT PUNE POLICY PDOV PCI PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PBT PP PS PG PY PTERE PGOF PALESTINIAN PKFK PSOE PEPR PPA PINT PMAR PRELP PSEPC PREFA PGOVE PINF PNG PMIL PGOC PFOR PCUL PLN PROP POLINT PGGV PHALANAGE PARTY PGOVLO PHUS PDEM PECON PROV PAS PHUMPREL PGIV PRAM PHUH PAO PSA PHUMPGOV PF PRL PHUMBA PEL PREO PAHO POGOV POV PNR PSI PINL PU PRGOV PAIGH POLITICAL PARTIES POSTS
QA
RS RCMP RICE RU REACTION REPORT REGION RIGHTS RO RW RF RM RFE RSP RP RIGHTSPOLMIL ROBERT RELATIONS ROOD RUPREL RSO
SOCI SN SY SNAR SENV SP SZ SCUL SA SO SW SMIG SU SENVKGHG SR SYRIA SF SI SC SWE SARS STEINBERG SG SIPRS ST SL SNARIZ SSA SK SPCVIS SOFA SEVN SIPDIS SAN SYR SHUM SANC SEN SPCE SNARCS SNARN SHI SH SAARC SCRS
TU TPHY TI TX TSPL TRGY TBIO TF TERRORISM TH TIP TC TSPA TW TZ TNGD TT TL TV TS TRSY TINT TN TURKEY TBID TD TP TAGS TK TR TFIN TO THPY
UK UNSC USTR UG UNGA UZ USEU US UN UNC USUN UP UY UNESCO USPS UNHRC UNO UNHCR UNCHR USAID UNVIE UAE UNMIK USOAS UNFICYP UV UNEP UNODC UNCHS UNIDROIT UNDESCO UNCHC UNDP UNAUS UNCND UNCSD UNICEF UNPUOS UNDC USNC UE
VT VZ VE VTEG VTPREL VM VI VTIZ VAT VC VN
WS WTO WTRO WTRQ WI WZ WHO WFP WWARD WHA WB WBG WIPO WITH WMO WEU WMD WHTI WA
XA XF XM XL XW XV XR XB XU XH XG XE XK XX XD XI XT XS XC XY XZ XTAG XQ
YE YM YI YMCS
ZI ZO ZU ZEALAND ZK ZR ZF ZP ZN ZA ZB ZOELLICK ZL ZANU ZJ

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 04WELLINGTON596, NEW ZEALAND-AUSTRALIA REGULATORY AGENCY TO RAISE

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #04WELLINGTON596.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
04WELLINGTON596 | 2004-07-13 04:34 | 2011-04-28 00:00 | CONFIDENTIAL | Embassy Wellington

`

    This record is a partial extract of the original cable. The full text of the original cable is not available.

` `

    C O N F I D E N T I A L SECTION 01 OF 02 WELLINGTON 000596

    SIPDIS

    STATE PASS USTR FOR BWEISEL
    STATE PASS FDA FOR OFFICE OF INTERNATIONAL PROGRAMS/WALTER
    BATTS AND JULIA HO
    STATE FOR EAP/ANP AND EB/TPP/BTA/ANA
    COMMERCE FOR 4530/ITA/MAC/AP/OSAO/GPAINE

    E.O. 12958: DECL: 07/12/2014
    TAGS: ETRD NZ
    SUBJECT: NEW ZEALAND-AUSTRALIA REGULATORY AGENCY TO RAISE
    INDUSTRY'S COSTS

    REF: A. AUCKLAND 118
         ¶B. 03 WELLINGTON 1273
         ¶C. 03 WELLINGTON 1191
         ¶D. 01 WELLINGTON 798

    (U) Classified by DCM David R. Burnett.  Reasons: 1.5 (b) and
    (d).

    ¶1. (C) Summary:  U.S. makers of medical devices and dietary
    and nutritional supplements face the prospect of additional
    regulatory costs to enter the New Zealand market -- but
    perhaps not as high as the industry had feared.  An
    Australian-New Zealand authority to regulate therapeutic
    products in both countries probably will accept U.S.
    certification of products, and not just European
    certification, as the industry had expected.  On the other
    hand, the agency will aim to recover all regulatory costs
    from the industry.  Representatives of U.S. manufacturers
    fear such costs could drive many of their products out of the
    New Zealand market.

    ¶2. (U) Meanwhile, the pharmaceutical industry has endorsed
    the joint authority, while worrying that the agency will ban
    direct-to-consumer advertising.  Such advertising has helped
    a number of pharmaceutical companies to boost sales of
    unsubsidized medicines in New Zealand.  It has provided one
    of the few means available in a highly restricted market for
    pharmaceutical manufacturers to build sales for products that
    consumers pay for entirely out of pocket.  End summary.

    New regulation
    --------------
    ¶3. (U) The Australian and New Zealand health ministers signed
    a treaty December 10 to set up a trans-Tasman agency to
    regulate therapeutic products, including medical devices,
    prescription and over-the-counter medicines, dietary and
    nutritional supplements, and cosmetics and toiletries (ref
    B).  When the agency opens its doors in July 2005, it will
    replace the Australian Therapeutic Goods Administration (TGA)
    and the New Zealand Medicines and Medical Devices Safety
    Authority (Medsafe).  Both governments are jointly working to
    establish a framework for the agency and instructions for any
    necessary legislation.

    ¶4. (U) For New Zealand, the agency offered a solution to a
    long-acknowledged deficiency.  Medical devices and
    health-care products have been virtually unregulated in the
    country.  Medsafe does evaluate pharmaceuticals before
    allowing them on the market.  An adviser to the health
    ministers suggested the cost to New Zealand of participating
    in the joint agency would be less than if it had tried on its
    own to extend its regulatory authority to devices and other
    non-drug medical products.

    Higher costs
    ------------
    ¶5. (C) Nonetheless, the adviser, Selwyn Katene, acknowledged
    that New Zealand's regulatory costs would increase
    significantly under the joint agency.  For example, the
    number of New Zealand-based staff members needed by the new
    agency would be at least double the 35 people who now staff
    Medsafe.  Moreover, Katene noted that all the agency's costs
    would be passed on to the industry.  Fees for registering
    products would be set to recover the costs of regulation,
    although Katene said his government recognizes it may need to
    phase in such fees to alleviate the pain to industry.  But
    with regulation over non-drug products, Katene said, "the
    industry's halcyon days are over."  Many distributors of
    medical devices and complementary goods expect the higher
    fees to harm their sales in New Zealand (ref C).  They
    advocate setting fees according to the size of the product's
    market, with Australia's population being five times that of
    New Zealand.

    ¶6. (C) The joint authority initially had intended to require
    additional documentation and possibly a quality-control audit
    for products that do not have European certification yet have
    U.S. Food and Drug Administration (FDA) approval.  However,
    Katene -- who asked that his comments July 9 not be shared
    with industry -- said New Zealand Minister of Health King had
    decided that requiring two certification processes was
    unreasonable.

    ¶7. (C) That decision should greatly relieve representatives
    of U.S. medical-device manufacturers, who have argued that
    additional certification would increase the cost and time for
    marketing their products.  A number of representatives met
    with King on June 25 and -- according to Katene -- influenced
    her thinking on the issue.  Katene, a New Zealander, serves
    as secretary to the joint agency's ministerial council, which
    is composed of the two health ministers.  They will appoint
    the agency's five governing board members.

    Advertising's future
    --------------------
    ¶8. (C) On June 17, the Researched Medicines Industry
    Association of New Zealand (RMI) -- the pharmaceutical
    industry association -- announced in a news release its
    support of the joint agency.  Lesley Clarke, RMI's chief
    executive, said July 9 that the association had long backed
    the concept of a joint authority, since it would provide one
    point of entry for pharmaceutical companies to both Australia
    and New Zealand.  RMI issued the news release to bolster
    parliamentary support for the agency, after the media
    reported that the agency's compliance requirements could put
    medical-device and complementary-goods companies out of
    business.

    ¶9. (C) However, the pharmaceutical industry worries that the
    new agency could mean an end to its ability to advertise its
    unsubsidized prescription medicines directly to New Zealand
    consumers (ref A).  Australia allows only disease-based,
    awareness-building advertising, with no mention of product
    names.  Some pharmaceutical companies have built a
    significant private purchase market in New Zealand -- in one
    case, as much as one-third of its sales -- as a way to
    counter the limits of a system of government-subsidized sales.

    ¶10. (C) On that issue, Katene would say only that Minister
    King had been instructed by the cabinet to "harmonize" with
    Australia and that a decision for or against
    direct-to-consumer advertising had not been made.
    "Harmonization" generally has been thought to refer to New
    Zealand's adopting the Australian rules, with Australia
    seeing no need to change.

    ¶11. (C) Clarke said that, other than Minister King, members
    of Parliament are supportive of or ambivalent about
    direct-to-consumer advertising.  Only Minister King appears
    to be adamantly against it, joining a small doctors' group --
    and no consumer groups -- that advocates a ban.  Clarke
    predicted that such advertising would continue to be allowed,
    with a ban requiring the repeal of existing law and with
    Minister King lacking her colleagues' support.

    ¶12. (C) Comment: Allowing FDA certification would remove one
    potentially discriminatory barrier to U.S. products.  Post
    remains concerned, however, about the potential decline in
    sales of U.S. medical devices and other therapeutic products
    due to anticipated higher regulatory costs and about the
    possibility that pharmaceutical companies -- already
    constrained by New Zealand government policy -- would lose
    their ability to generate private sales through advertising.
    Post hopes these concerns could be conveyed in the Trade and
    Investment Framework Agreement talks with New Zealand
    scheduled for July 20.
    Swindells

`